References
- Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 heart disease and stroke statistics: A report of US and global data from the American Heart Association. Circulation. 2024;149(8):e347–e913. DOI: 10.1161/CIR.0000000000001209
- Kazi DS, Elkind MSV, Deutsch A, Dowd WN, Heidenreich P, Khavjou O, et al. Forecasting the economic burden of cardiovascular disease and stroke in the United States through 2050: A presidential advisory from the American Heart Association. Circulation. 2024;150(4):e89–e101. DOI: 10.1161/CIR.0000000000001258
- de Araújo JM, Eufrosino de Alencar Rodrigues R, da Costa Pereira de Arruda Neta A, Leite Lima Ferreira FE, Lira Formiga Cavalcanti de Lima R, Pinheiro de Toledo Vianna R, et al. The direct and indirect costs of cardiovascular diseases in Brazil. PLoS One. 2022;17(12):
e0278891 . DOI: 10.1371/journal.pone.0278891 - Marquina C, Talic S, Vargas-Torres S, Petrova M, Abushanab D, Owen A, et al. Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029. European Journal of Preventive Cardiology. 2022;29(8):1212–1219. DOI: 10.1093/eurjpc/zwab001
- CDC. Lipoprotein (a) [Internet]. 2022; [cited 2024 Apr 18]. Available from:
https://www.cdc.gov/genomics/disease/lipoprotein_a.htm - CDC. Familial hypercholesterolemia [Internet]. 2023; [cited 2024 Apr 18]. Available from:
https://www.cdc.gov/genomics/disease/fh/FH.htm - Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Journal of the American College of Cardiology. 2019;73(24):e285–e350. DOI: 10.1016/j.jacc.2018.11.003
- Ray KK, Haq I, Bilitou A, Manu MC, Burden A, Aguiar C, et al. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: The multinational observational SANTORINI study. The Lancet Regional Health: Europe. 2023;29:
100624 . DOI: 10.1016/j.lanepe.2023.100624 - Gu J, Sanchez R, Chauhan A, Fazio S, Wong N. Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update. American Journal of Preventive Cardiology. 2022;10:
100336 . DOI: 10.1016/j.ajpc.2022.100336 - Santo K, Santos RD, Girotto AN, Nieri J, Monfardini F, Raupp P, et al. Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil. Journal of Clinical Lipidology. 2024;18(3):e384–e393. DOI: 10.1016/j.jacl.2024.02.005
- Kotseva K. The EUROASPIRE surveys: Lessons learned in cardiovascular disease prevention. Cardiovascular Diagnosis and Therapy. 2017;7(6):633–639. DOI: 10.21037/cdt.2017.04.06
- EuroAspire VI [Internet]. [cited 2024 Dec 11]. Available from:
https://www.escardio.org/Research/registries/global-registries-and-surveys-programme/euroaspire-vi - Jansen J, McKinn S, Bonner C, Muscat DM, Doust J, McCaffery K. Shared decision-making about cardiovascular disease medication in older people: A qualitative study of patient experiences in general practice. BMJ Open. 2019;9(3):
e026342 . DOI: 10.1136/bmjopen-2018-026342 - Lönnberg L, Damberg M, Revenäs Å. “It’s up to me”: The experience of patients at high risk of cardiovascular disease of lifestyle change. Scandinavian Journal of Primary Health Care. 2020;38(3):340–351. DOI: 10.1080/02813432.2020.1794414
- Burger SA, Poots A, Perris A, Crump H, Thorne H, Hughes S, et al. Living with cardiovascular disease (CVD): Exploring the biggest challenges for people affected by CVD in the UK, and their use (or not) of online resources. Patient Experience Journal. 2020;7(3):83–97. DOI: 10.35680/2372-0247.1418
- Beh CY, Fok RWY, Goh LH. Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: A qualitative study in Singapore. BMJ Open. 2023;13(9):
e073125 . DOI: 10.1136/bmjopen-2023-073125 - Qureshi N, Cornel JH, Schiele F, Perrone-Filardi P, Brachmann J, Sidelnikov E, et al. POSC227 what are the main barriers for achieving low-density lipoprotein cholesterol goals in post myocardial infarction patients? Perspectives from physicians in six European countries. Value in Health. 2022;25(1):
S163 . DOI: 10.1016/j.jval.2021.11.794 - Chalasani M, Vaidya P, Mullin T. Enhancing the incorporation of the patient’s voice in drug development and evaluation. Research Involvement and Engagement [Internet]. 2018;4. DOI: 10.1186/s40900-018-0093-3
- Hoos A, Anderson J, Boutin M, Dewulf L, Geissler J, Johnston G, et al. Partnering with patients in the development and lifecycle of medicines: A call for action. Therapeutic Innovation & Regulatory Science. 2015;49(6):929–939. DOI: 10.1177/2168479015580384
- Oehrlein EM, Schoch S, Majercak K, Gressler LE, Costantino RC, Love TR, et al. Development and testing of a chronic-disease patient experience mapping toolbox. Patient. 2024;17(3):263–274. DOI: 10.1007/s40271-023-00658-3
- Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Social Science & Medicine. 2022;292:
114523 . DOI: 10.1016/j.socscimed.2021.114523 - Giesen L, Roeser A. Structuring a team-based approach to coding qualitative data. International Journal of Qualitative Methods. 2020;19:1609406920968700. DOI: 10.1177/1609406920968700
- ATLAS.ti [Internet]. [cited 2024 Apr 1]. ATLAS.ti. Available from:
https://atlasti.com - O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: A synthesis of recommendations. Academic Medicine. 2014;89(9):
1245 . DOI: 10.1097/ACM.0000000000000388 - European Commission announces EU Cardiovascular Health Plan [Internet]. [cited 2024 Dec 11]. Available from:
https://www.escardio.org/The-ESC/Press-Office/Press-releases/eu-health-ministers-adopt-landmark-council-conclusions-on-cardiovascular-health - Pinto FJ, Harding E, Fenton O. A Manifesto from Global Heart Hub for early detection and diagnosis of cardiovascular disease. European Heart Journal. 2024;46(4):339–340. DOI: 10.1093/eurheartj/ehae455
- Forsey J, Ng S, Rowland P, Freeman R, Li C, Woods NN. The basic science of patient-physician communication: A critical scoping review. Academic Medicine. 2021;96(11S):S109–S118. DOI: 10.1097/ACM.0000000000004323
- Dennison Himmelfarb CR, Beckie TM, Allen LA, Commodore-Mensah Y, Davidson PM, Lin G, et al. Shared decision-making and cardiovascular health: A scientific statement from the American Heart Association. Circulation. 2023;148(11):912–931. DOI: 10.1161/CIR.0000000000001162
- Zurynski Y, Smith C, Siette J, Easpaig BNG, Simons M, Knaggs GT. Identifying enablers and barriers to referral, uptake and completion of lifestyle modification programmes: A rapid literature review. BMJ Open. 2021;11(3):
e045094 . DOI: 10.1136/bmjopen-2020-045094 - US Department of Health and Human Services. 45 CFR 46.104 — Exempt research. [Internet]. [cited 2024 Jul 24]. Available from:
https://www.ecfr.gov/current/title-45/part-46/section-46.104 - National Health Council. Fair Market Calculator. [Internet]. [cited 2023 Oct 13]. Available from:
https://nationalhealthcouncil.org/fair-market-value-calculator/